NuGen Medical Devices
NuGen Medical Devices is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. Their principal business involves research, development, and commercialization of innovative needle-free injection devices and systems for subcutaneous medication. They aim to improve healthcare by providing safe, pain-free, and empowering drug delivery solutions for various medical fields including diabetes, vaccines, and more. Their devices are approved in over 40 countries and are designed to benefit millions of people worldwide. The company continues to expand its market presence through strategic partnerships, regulatory approvals, and innovative product launches.
Industries
Nr. of Employees
small (1-50)
NuGen Medical Devices
Products
Reusable jet-based needle-free injector for subcutaneous therapy
A reusable jet-driven needle-free injector designed for self-administration of subcutaneous medications, supported by replaceable consumables and starter packs intended for chronic therapy management.
Needle-free injector adapted for veterinary use
A needle-free injection device adapted for use in domesticated animals, incorporating safety and lifecycle specifications appropriate for veterinary administration.
Reusable jet-based needle-free injector for subcutaneous therapy
A reusable jet-driven needle-free injector designed for self-administration of subcutaneous medications, supported by replaceable consumables and starter packs intended for chronic therapy management.
Needle-free injector adapted for veterinary use
A needle-free injection device adapted for use in domesticated animals, incorporating safety and lifecycle specifications appropriate for veterinary administration.
Services
Establishing and managing regional and exclusive distribution agreements, managing distributor relationships and supporting market launches and recurring consumable supply.
Operation of online brand stores and consumer subscription services to enable direct purchase of devices, starter packs and recurring consumables.
Creation and delivery of pharmacist training packages, distributor education and end-user tutorials to support safe device use and market rollouts.
Establishing and managing regional and exclusive distribution agreements, managing distributor relationships and supporting market launches and recurring consumable supply.
Operation of online brand stores and consumer subscription services to enable direct purchase of devices, starter packs and recurring consumables.
Creation and delivery of pharmacist training packages, distributor education and end-user tutorials to support safe device use and market rollouts.
Expertise Areas
- Needle-free drug delivery systems
- Medical device research and development
- Clinical evaluation for subcutaneous delivery
- Regulatory compliance and device approvals
Key Technologies
- Jet-based needle-free injection
- Reusable device architecture with replaceable consumables
- Injection molding for medical components
- Sterile packaging and sterilization processes
News & Updates
NuGen M.D. announced it received approval from Health Canada for InsuJet™, its needle-free injection system, which is the first self-administered needle-free system approved by Health Canada.
NuGen announced that its devices are now eligible for direct-to-consumer sales in the U.S., expanding access to their needle-free drug delivery systems.
NuGen signed a distribution agreement with Verrue Consulting Group in Belgium for the InsuJet™ system, expanding its market reach.
NuGen announced the launch of PetJet™, a needle-free injection device for pets, reducing fear and injury risk for pet owners and animals.
First self-administered, needle-free injection system approved by Health Canada, enabling safe, pain-free drug delivery.
NuGen M.D. announced it received approval from Health Canada for InsuJet™, its needle-free injection system, which is the first self-administered needle-free system approved by Health Canada.
NuGen announced that its devices are now eligible for direct-to-consumer sales in the U.S., expanding access to their needle-free drug delivery systems.
NuGen signed a distribution agreement with Verrue Consulting Group in Belgium for the InsuJet™ system, expanding its market reach.
NuGen announced the launch of PetJet™, a needle-free injection device for pets, reducing fear and injury risk for pet owners and animals.
First self-administered, needle-free injection system approved by Health Canada, enabling safe, pain-free drug delivery.